Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
HT-1197
Cat.No.: CSC-C9438L
Species: Homo sapiens (human)
Culture Properties: monolayer
- Specification
- Q & A
- Customer Review
Tumorigenecity: yes, in mice and hamsters
Isoenzyme: G6PD, B
Production: fibrinolytic activity
Histopathology: carcinoma
Note: the cells will grow in soft agar
vWA: 16,18
FGA: 20,23
Amelogenin: X,Y
TH01: 6,9.3
TPOX: 11,12
CSF1P0: 11,12
D5S818: 12
D13S317: 11,12
D7S820: 11,12
The day before cell lyophilization, it is better to change the culture medium once; when lyophilizing, it is also better to use freshly prepared culture medium.
Ask a Question
Average Rating: 5.0 | 1 Scientist has reviewed this product
Satisfied
We chose Creative Bioarray's cellular products after being recommended by others. We are very satisfied them so far.
18 Nov 2022
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: These cells were thought to be "stablished from the malignant urinary bladder carcinoma of a 66-year-old Caucasian man (stage pTa G3) in 1989"; same donor as for cell line BT-A; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA
Description: These cells were thought to be "established from the malignant urinary bladder carcinoma of a 82-year-old Caucasian woman (stage pTa G1-G2) in 1992"; same donor as for cell line SBC-7; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA
Description: These cells were thought to be "established from the malignant urinary bladder carcinoma of a 82-year-old Caucasian woman (stage pTa G1-G2) in 1992"; same donor as for cell line SBC-2; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA
Description: Established from a 51-year-old Chinese woman with a grade III papillary transitional cell carinoma of the urinary bladder in 1990; patient lived in a blackfoot disease endemic area in Taiwan
Description: Established from the tumor specimen resected from the urinary bladder transitional cell carcinoma (undifferentiated, grade IV) of a 67-year-old woman in 1974 (without therapy)
Description: Established from the invasive transitional cell carcinoma of the bladder (grade 3, pT3b) of a 76-year-old man in 1993; described as secreting several hematopoietic cytokines and chorionic gonadotropin
